Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24972444 | 0.89 | KDM4E (0.35) | KDM4EMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL24315014 | 0.84 | GPR84 (0.30) | GPR84PRKDC | |
| SCHEMBL24315115 | 0.83 | PRKDC (0.34) | KDM4EMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL26375443 | 0.83 | PRKDC (0.35) | KDM4EMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL24971374 | 0.82 | GPR84 (0.32) | GPR84KDM4EMEN1ALDH1A1TP53 | |
| SCHEMBL26036239 | 0.82 | GPR84 (0.32) | GPR84 | |
| SCHEMBL24973289 | 0.81 | PRKDC (0.32) | GPR84PRKDC | |
| SCHEMBL23821316 | 0.81 | GPR84 (0.39) | GPR84KDM4EMEN1ALDH1A1TP53 | |
| SCHEMBL24356360 | 0.81 | MAPK10 (0.31) | — | |
| SCHEMBL26326973 | 0.81 | KDM4E (0.33) | KDM4EALDH1A1TP53SMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023002447-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |